Healthscape
area at your fingertips in HealthScape
Main features
Identify thought leaders
Browse & Filter thought leaders and physicians in your therapeutic area. Filter them according to the criteria of your current use case to identify the right people for any situation. Compare leaders based on all dimensions of our vast dataset.
Profile leaders
Get an integrated summary of all publicly available information (Publications, Trials, Society blog posts, Events etc) for your people of interest at your fingertips. Distinguish fresh topics of interest from long standing medical interests, learn about frequent / new collaborators and about your competitor’s view on a leader.
Custom Data
You would like to cross-reference additional data into HealthScape? No problem! You can easily import internal data, data you bought from other vendors or ask us to include some public data you need. Once taught, the Artificial Intelligence (AI) underlying our data can access all publicly available information about hospitals and people in your therapeutic area.
Data Updates
Always work with the latest information about your leaders: Our data is updates multiple times a day. Learn about changes in the data through our News Feed, enabling you to filter and visualize the updates over time. This ensures that you can always feel the pulse of your therapeutic area, discover emerging topics of interest early on and track your competition.
Save & Follow
There are usually some critical KOL’s for whom you’d like to know about every step they take. Never miss diamonds in the rough by subscribing to updates of groups of people. You can define the granularity and frequency of your notifications such that you only get emails about activities that you care about.
GDPR
The new data protection law covers all citizen of the European Union – including data about KOL’s. We are fully GDPR compliant and passed reviews of multiple compliance departments of large European Pharmaceutical companies. Let us handle the data-related challenges, so you can focus on doing your job – more convenient than ever.
World Coverage
USA
>1M people
~200k sites
Great Britain
~4k sites
France
~400k sites
Germany
~300k sites
Italy
~1.5k hospitals
Norway
~120k people
~50k organizations
Switzerland
~40k physicians
~3k sites
Blog
Influence mapping for KAM is a key differentiator for Pharma
Rob Wood, founder of STEM, today commented that of the 1000’s of account managers audited by STEM across the entire industry that two things are clear. Firstly, that ‘Influence Mapping’ is the biggest opportunity for companies to enhance the effectiveness of their account plans and that secondly, when you compare the top quartile account managers […]
Role of AI in drug commercialisation
The role of AI in the biopharmaceutical sector to date has focused mostly on optimising and accelerating R&D processes and on innovating clinical trials. Those activities belong to the pre-commercialisation stage of bringing a new therapy to market, and have historically absorbed the lion’s share of investment and attention in the industry. But with companies […]
Unravelling the power of Big Data to increase sales team effectiveness
Commercial teams nowadays are being asked to deliver sales pitches while swimming in an ocean of product, customer, and performance data. This is nowhere more challenging than in the highly regulated pharmaceutical industry, where promoting new treatments must be calibrated so as to grab the attention of busy clinicians with little spare time and convert […]
Building new capabilities into Medical Affairs
Over the past few years, physicians and other KOLs have been increasingly mindful of the time they spend with pharma sales representatives. Many of them have been reducing this time investment in favour of engaging with more scientifically knowledgeable MSL’s (Medical Science Liaisons) that can double as educators and help them stay abreast of new […]
Connected Opinion Leaders (COLs): a new ally for pharma marketers
Influencer ecosystems are continually evolving in response to changing consumer preferences and the pharmaceutical sector is no exception. On one hand, patients and their doctors are looking beyond traditional Key Opinion Leaders (KOLs) for guidance on therapies and treatments and want to hear from alternative sources, such as Patient Opinion Leaders (POLs), whose feedback resonates […]
Get our newsletter
To recieve latest news about drug commercialisation and Artificial Intelligence
